Pentavalent antimonials are first-line drugs for the treatment of the cutaneous form of
American tegumentary leishmaniasis. Second-line drugs include amphotericin B and …

Recent epidemiologic studies indicate that leishmaniasis in the Americas is far more
abundant and of greater public health importance than was previously recognized. The …

The current interest in leishmaniasis stems from the importance of this disease with respect
to travel medicine, veterans of Operation Desert Storm, humanitarian concerns, and infection …

The 1980s have seen significant advances in the treatment of cutaneous, mucosal, and
visceral leishmaniasis. Safe regimens of pentavalent antimony in the form of Pentostam …

Pentavalent antimonial compounds have been the mainstay of the treatment of visceral,
cutaneous, and mucosal leishmaniasis for approximately half a century. Pentostam (sodium …

Leishmaniasis is endemic in 88 countries on five continents. There are 1–1.5 million cases
of cutaneous leishmaniasis reported yearly worldwide. There has been a sharp increase in …

Cutaneous leishmaniasis (CL) is a complex skin infection that has imposed a heavy burden
on many developing countries and is caused by more than 20 Leishmania species. This …

To determine the relative efficacy and toxicity of stibogluconate and ketoconazole for the
treatment of cutaneous leishmaniasis, a comparative trial was conducted in which 120 …

Estimated worldwide incidence of tegumentary leishmaniasis (cutaneous leishmaniasis [CL]
and mucocutaneous leishmaniasis [MCL]) is over 1.5 million cases per year in 82 countries …

We conducted a quasi-experimental study to compare the response to meglumine
antimoniate in patients with localized cutaneous leishmaniasis from two endemic areas of …